In addition, many other components of the TCR-signaling pathways such as phospholipase Cγ1 (14%), CD28 (9–11%), Src family tyrosine kinase (FYN) (3–4%), and VAV1 (50%) are mutated in AITL. This evidence concerns the gene CD28 and angioimmunoblastic T-cell lymphoma.